NXT629
NXT629 is a potent and selective PPAR-α antagonist that also inhibits PPARδ, PPARγ, ERβ, GR, and TRβ. It has demonstrated anticancer activity in research, with studies investigating its effects in models of ovarian cancer and melanoma both in vitro and in vivo.
Product Specifications
CAS Number
1454925-59-7
Product Name Alternative
NXT 629, NXT629, NXT-629, EstrogenReceptor, GR, Estrogen Receptor, ERβ, hPPARα, hPPARγ, hPPARδ, progestogenReceptor, progestogen Receptor
Field of Research
Metabolism Research, Molecular Biology
Purity
99.07% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (6.56 mM) ; DMSO:100 mg/mL (163.99 mM)
Smiles
O=C1N (N=C (N1CC) CCCC=2C=CC (=CC2) C3=NC=C (C=C3) NS (=O) (=O) C=4C=CC=CC4) CC5=CC=C (C=C5) C (C) (C) C
Molecular Formula
C35H39N5O3S
Molecular Weight
609.78
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Explore Other Products
Browse additional items from our catalog
Recombinant Petromyzon marinus NADH-ubiquinone oxidoreductase chain 4 (MT-ND4), partial
LC3A Monoclonal Antibody, Biotin Conjugated
